BusinessElite Pharmaceuticals Reports Topline Results from a Pivotal Fed Bioequivalence Study for SequestOx™By Nasdaq OMXJul 7, 2017, 4:48 PM UTC
BusinessElite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study for a Generic OxyContin®By Nasdaq OMXJan 17, 2017, 1:00 PM UTC
